105 related articles for article (PubMed ID: 19300412)
1. Synthesis and evaluation of dimethyl tin 4-cyclohexyl thiosemicarbazone as a novel antitumor agent.
Sen A; Chaudhuri TK
Exp Oncol; 2009 Mar; 31(1):22-6. PubMed ID: 19300412
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
4. Deoxyribonucleic acid synthetic response of mouse lymphoid cells in microculture with T-lymphocyte-dependent mitogens.
Williams RM; Benacerraf B
Lab Invest; 1975 Mar; 32(3):382-7. PubMed ID: 1079068
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell proliferation and antitumor activity of a novel organotin compound.
Syng-Ai C; Basu Baul TS; Chatterjee A
J Environ Pathol Toxicol Oncol; 2001; 20(4):333-42. PubMed ID: 11797843
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
Amishiro N; Okamoto A; Murakata C; Tamaoki T; Okabe M; Saito H
J Med Chem; 1999 Jul; 42(15):2946-60. PubMed ID: 10425104
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific immune responsiveness of the tumor-bearing host.
Burk MW; Yu S; McKhann CF
Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism.
Simoni D; Gebbia N; Invidiata FP; Eleopra M; Marchetti P; Rondanin R; Baruchello R; Provera S; Marchioro C; Tolomeo M; Marinelli L; Limongelli V; Novellino E; Kwaasi A; Dunford J; Buccheri S; Caccamo N; Dieli F
J Med Chem; 2008 Nov; 51(21):6800-7. PubMed ID: 18937434
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
Samanta S; Pain A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives.
Hu K; Yang ZH; Pan SS; Xu HJ; Ren J
Eur J Med Chem; 2010 Aug; 45(8):3453-8. PubMed ID: 20494492
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.
Stanisz AM; Befus D; Bienenstock J
J Immunol; 1986 Jan; 136(1):152-6. PubMed ID: 2415614
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
Kaplan JM; Badger AM; Ruggieri EV; Olivera DL; Newman-Tarr T; Bugelski PJ
J Clin Lab Immunol; 1991 Dec; 36(4):49-58. PubMed ID: 1668843
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride.
Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q
J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534
[TBL] [Abstract][Full Text] [Related]
15. Activation of murine thymocytes in vivo. Part II: Study of blastogenesis, the synthesis of macromolecules and the cytotoxic response after stimulation with phytohemagglutinin.
Chaudhuri TK; Chakravarty AK
Lymphology; 1986 Sep; 19(3):117-24. PubMed ID: 2431234
[TBL] [Abstract][Full Text] [Related]
16. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
Shu SY; Chou T; Rosenberg SA
J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816
[TBL] [Abstract][Full Text] [Related]
17. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives.
de Oliveira RB; de Souza-Fagundes EM; Soares RP; Andrade AA; Krettli AU; Zani CL
Eur J Med Chem; 2008 Sep; 43(9):1983-8. PubMed ID: 18222568
[TBL] [Abstract][Full Text] [Related]
19. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Masuda E; Maeda H
Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
[TBL] [Abstract][Full Text] [Related]
20. Human tumor gangliosides inhibit murine immune responses in vivo.
Li R; Villacreses N; Ladisch S
Cancer Res; 1995 Jan; 55(2):211-4. PubMed ID: 7812945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
